April 18, 2018: Here are four stocks trading with heavy volume among 15 equities making new 52-week lows in Wednesday’s session. On the NYSE advancers led decliners by about 8 to 7 and on the Nasdaq, advancers led decliners by about the same ratio.
MGIC Investment Corp. (NYSE: MTG) traded down about 6.5% Wednesday to post a new 52-week low of $10.07 after closing Tuesday at $10.77. The stock’s 52-week high is $16.21. Volume was more than double the daily average of around 4.2 million shares. The company reported uninspiring first-quarter results this morning.
Celldex Therapeutics Inc. (NASDAQ: CLDX) fell by about 7.6% Wednesday to post a new 52-week low of $0.72 after closing at $0.79 on Tuesday. The 52-week high is $3.42. Volume of about 9 million was more than four times the daily average of about 2 million. The company continues to get beaten up following a failed breast cancer drug study.
Juniper Networks Inc. (NYSE: JNPR) traded down about 7.1% Wednesday and posted a new 52-week low of $23.61 after closing Tuesday at $25.41. The stock’s 52-week high is $30.96. Volume totaled around 8.5 million, about double the daily average. The company had no specific news.
Healthcare Services Group Inc. (NASDAQ: HCSG) dropped about 13.7% Wednesday to post a new 52-week low of $35.04. Shares closed at $40.60 on Tuesday and the stock’s 52-week high is $56.20. Volume was about four times the daily average of around 1.2 million shares. The company reported weak results last night and the stock took a downgrade from Buy to Hold for Stifel Nicolaus. The price target was also lowered from $57 to $44.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.